Venus Concept Inc. (VERO)
USD 2.39
(5.75%)
USD 2.39
(5.75%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 80.47 Million USD | -20.2% |
| 2022 | 100.84 Million USD | 10.05% |
| 2021 | 91.63 Million USD | -0.22% |
| 2020 | 91.83 Million USD | -5.26% |
| 2019 | 96.94 Million USD | 173.75% |
| 2018 | 35.41 Million USD | 33.99% |
| 2017 | 26.42 Million USD | 9.66% |
| 2016 | 24.1 Million USD | -4.52% |
| 2015 | 25.24 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 17.44 Million USD | -10.11% |
| 2024 Q1 | 19.4 Million USD | -1.47% |
| 2023 Q3 | 18.94 Million USD | -5.16% |
| 2023 Q4 | 19.69 Million USD | 3.96% |
| 2023 Q2 | 19.97 Million USD | -8.58% |
| 2023 FY | 80.47 Million USD | -20.2% |
| 2023 Q1 | 21.85 Million USD | -11.44% |
| 2022 FY | 100.84 Million USD | 10.05% |
| 2022 Q4 | 24.67 Million USD | -0.49% |
| 2022 Q3 | 24.79 Million USD | -5.25% |
| 2022 Q2 | 26.17 Million USD | 3.86% |
| 2022 Q1 | 25.19 Million USD | -6.34% |
| 2021 Q2 | 19.96 Million USD | -9.53% |
| 2021 Q1 | 22.07 Million USD | -16.85% |
| 2021 FY | 91.63 Million USD | -0.22% |
| 2021 Q3 | 22.69 Million USD | 13.67% |
| 2021 Q4 | 26.9 Million USD | 18.55% |
| 2020 Q3 | 18.79 Million USD | -10.87% |
| 2020 Q2 | 21.09 Million USD | -17.0% |
| 2020 FY | 91.83 Million USD | -5.26% |
| 2020 Q4 | 26.54 Million USD | 41.2% |
| 2020 Q1 | 25.41 Million USD | -16.85% |
| 2019 Q4 | 30.55 Million USD | 296.3% |
| 2019 FY | 96.94 Million USD | 173.75% |
| 2019 Q3 | 7.71 Million USD | 6.79% |
| 2019 Q2 | 7.22 Million USD | -10.3% |
| 2019 Q1 | 8.05 Million USD | -18.02% |
| 2018 Q1 | 8.86 Million USD | 34.96% |
| 2018 Q2 | 8.13 Million USD | -8.18% |
| 2018 Q3 | 8.59 Million USD | 5.68% |
| 2018 Q4 | 9.81 Million USD | 14.21% |
| 2018 FY | 35.41 Million USD | 33.99% |
| 2017 Q1 | 6.8 Million USD | 15.39% |
| 2017 FY | 26.42 Million USD | 9.66% |
| 2017 Q2 | 6.74 Million USD | -0.9% |
| 2017 Q3 | 6.3 Million USD | -6.49% |
| 2017 Q4 | 6.56 Million USD | 4.06% |
| 2016 FY | 24.1 Million USD | -4.52% |
| 2016 Q3 | 6.59 Million USD | 0.0% |
| 2016 Q4 | 5.9 Million USD | -10.58% |
| 2015 FY | 25.24 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Acutus Medical, Inc. | 11.22 Million USD | -616.999% |
| Cerus Corporation | 143.15 Million USD | 43.784% |
| OrthoPediatrics Corp. | 137.01 Million USD | 41.267% |
| PetVivo Holdings, Inc. | 11.36 Million USD | -608.361% |
| Talis Biomedical Corporation | 67.18 Million USD | -19.781% |
| Vivos Therapeutics, Inc. | 24.94 Million USD | -222.601% |
| Inogen, Inc. | 236.08 Million USD | 65.912% |
| Spectral AI, Inc. | 20.86 Million USD | -285.717% |
| Nano-X Imaging Ltd. | 55.99 Million USD | -43.715% |
| CVRx, Inc. | 76.14 Million USD | -5.692% |
| DIH Holding US, Inc. Warrants | 3.52 Million USD | -2181.068% |
| Helius Medical Technologies, Inc. | 12.48 Million USD | -544.375% |
| Orthofix Medical Inc. | 667.42 Million USD | 87.942% |
| Accelerate Diagnostics, Inc. | 56.57 Million USD | -42.239% |
| Bioventus Inc. | 409.91 Million USD | 80.368% |
| BrainsWay Ltd. | 28.01 Million USD | -187.23% |
| Envoy Medical, Inc. | 17.89 Million USD | -349.637% |
| electroCore, Inc. | 32.03 Million USD | -151.244% |
| IceCure Medical Ltd | 16.87 Million USD | -376.867% |
| Lucid Diagnostics Inc. | 42.43 Million USD | -89.659% |
| Monogram Orthopaedics, Inc. | 17.63 Million USD | -356.394% |
| MaxCyte, Inc. | 84.84 Million USD | 5.149% |
| NeuroOne Medical Technologies Corporation | 12.41 Million USD | -548.385% |
| Nexalin Technology, Inc. | 5.78 Million USD | -1291.992% |
| PAVmed Inc | 64.82 Million USD | -24.14% |
| Rapid Micro Biosystems, Inc. | 51.07 Million USD | -57.555% |
| RxSight, Inc. | 103.85 Million USD | 22.507% |
| Sight Sciences, Inc. | 126.44 Million USD | 36.357% |
| SI-BONE, Inc. | 156.35 Million USD | 48.529% |
| TELA Bio, Inc. | 84.18 Million USD | 4.408% |
| TriSalus Life Sciences, Inc. | 70.05 Million USD | -14.874% |
| Treace Medical Concepts, Inc. | 203.36 Million USD | 60.428% |
| LivaNova PLC | 843.54 Million USD | 90.46% |
| 908 Devices Inc. | 68.08 Million USD | -18.208% |
| Alphatec Holdings, Inc. | 483.59 Million USD | 83.359% |
| Nemaura Medical Inc. | 7.13 Million USD | -1027.304% |
| NeuroPace, Inc. | 75.29 Million USD | -6.88% |
| LENSAR, Inc. | 33.33 Million USD | -141.409% |
| Apyx Medical Corporation | 51.01 Million USD | -57.74% |
| Cutera, Inc. | 197.72 Million USD | 59.299% |
| STRATA Skin Sciences, Inc. | 24.78 Million USD | -224.749% |
| BioSig Technologies, Inc. | 28.53 Million USD | -182.075% |
| Anika Therapeutics, Inc. | 191.47 Million USD | 57.97% |
| ClearPoint Neuro, Inc. | 36.06 Million USD | -123.172% |
| Integra LifeSciences Holdings Corporation | 836.39 Million USD | 90.378% |
| Axonics, Inc. | 270.2 Million USD | 70.216% |
| Outset Medical, Inc. | 198.77 Million USD | 59.513% |
| IRIDEX Corporation | 31.81 Million USD | -152.958% |
| PROCEPT BioRobotics Corporation | 180.21 Million USD | 55.345% |
| IRadimed Corporation | 30.12 Million USD | -167.16% |
| Tivic Health Systems, Inc. | 8.53 Million USD | -843.226% |
| INVO Bioscience, Inc. | 7.85 Million USD | -924.742% |
| Telesis Bio, Inc. | 63.48 Million USD | -26.756% |
| Viemed Healthcare, Inc. | 98.45 Million USD | 18.259% |
| Varex Imaging Corporation | 224.8 Million USD | 64.201% |
| Quipt Home Medical Corp. | 148.66 Million USD | 45.868% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -586.48% |
| Pulmonx Corporation | 112.68 Million USD | 28.584% |
| Dynatronics Corporation | 9.9 Million USD | -712.23% |
| Modular Medical, Inc. | 17.52 Million USD | -359.102% |
| ReShape Lifesciences Inc. | 20.18 Million USD | -298.653% |
| Semler Scientific, Inc. | 38.94 Million USD | -106.645% |
| InMode Ltd. | 215.68 Million USD | 62.687% |
| Bruker Corporation | 1.07 Billion USD | 92.524% |
| Cytosorbents Corporation | 48.33 Million USD | -66.49% |
| DexCom, Inc. | 1.69 Billion USD | 95.241% |
| Align Technology, Inc. | 2.07 Billion USD | 96.125% |
| Viveve Medical, Inc. | 22.17 Million USD | -262.946% |
| ZimVie Inc. | 275.12 Million USD | 70.749% |
| Movano Inc. | 29.69 Million USD | -171.054% |
| Cytek Biosciences, Inc. | 137.27 Million USD | 41.374% |
| Nexalin Technology, Inc. | 5.78 Million USD | -1291.992% |
| DIH Holdings US, Inc. Class A Common Stock | 3.52 Million USD | -2181.068% |
| Tandem Diabetes Care, Inc. | 600.92 Million USD | 86.608% |
| Profound Medical Corp. | 33.6 Million USD | -139.489% |
| Insulet Corporation | 939.9 Million USD | 91.438% |
| enVVeno Medical Corporation | 25.23 Million USD | -218.868% |
| Surmodics, Inc. | 98.69 Million USD | 18.462% |
| iCAD, Inc. | 22.22 Million USD | -262.097% |
| Nuwellis, Inc. | 22.61 Million USD | -255.884% |
| Biotricity, Inc. | 17.18 Million USD | -368.304% |
| iRhythm Technologies, Inc. | 445.88 Million USD | 81.952% |
| Aethlon Medical, Inc. | 12.27 Million USD | -555.475% |
| InspireMD, Inc. | 22.95 Million USD | -250.658% |
| PAVmed Inc. | 64.82 Million USD | -24.14% |
| BIOLASE, Inc. | 34.66 Million USD | -132.18% |
| Beyond Air, Inc. | 61.7 Million USD | -30.431% |
| FONAR Corporation | 28.6 Million USD | -181.339% |
| AxoGen, Inc. | 149.33 Million USD | 46.111% |
| Vivani Medical, Inc. | 26.96 Million USD | -198.446% |
| Tactile Systems Technology, Inc. | 177.09 Million USD | 54.557% |
| Inari Medical, Inc. | 448.59 Million USD | 82.06% |
| UFP Technologies, Inc. | 58.08 Million USD | -38.539% |
| QT Imaging Holdings, Inc. | 4.92 Million USD | -1533.169% |
| Heart Test Laboratories, Inc. | 6.31 Million USD | -1173.699% |
| Tenon Medical, Inc. | 16.96 Million USD | -374.281% |
| Autonomix Medical, Inc. Common Stock | 7.39 Million USD | -988.543% |
| Co-Diagnostics, Inc. | 44.1 Million USD | -82.473% |
| AdaptHealth Corp. | 1.07 Billion USD | 92.534% |
| Sintx Technologies, Inc. | 15.2 Million USD | -429.413% |
| NanoVibronix, Inc. | 4.97 Million USD | -1518.259% |
| Quanterix Corporation | 118.1 Million USD | 31.858% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -586.48% |
| Sensus Healthcare, Inc. | 14.44 Million USD | -457.236% |
| Pacific Biosciences of California, Inc. | 392.66 Million USD | 79.505% |
| TransMedics Group, Inc. | 182.82 Million USD | 55.981% |
| ReWalk Robotics Ltd. | 28.06 Million USD | -186.749% |
| NeuroMetrix, Inc. | 11.09 Million USD | -625.079% |
| Hyperfine, Inc. | 52.87 Million USD | -52.209% |
| Establishment Labs Holdings Inc. | 172 Million USD | 53.212% |
| Biomerica, Inc. | 6.97 Million USD | -1053.282% |
| Bone Biologics Corporation | 9.42 Million USD | -753.558% |
| AVITA Medical, Inc. | 80.77 Million USD | 0.375% |
| Bluejay Diagnostics, Inc. | 10.31 Million USD | -680.471% |
| Silk Road Medical, Inc | 186.35 Million USD | 56.816% |